ADPT Past Earnings image   This ADPT past earnings page last updated 11/22/2024
ADPT Past Earnings
PeriodPast Earnings DateGAAP
Q3 202411/7/2024-0.220
Q2 20248/1/2024-0.310
Q1 20245/7/2024-0.330
Q4 20232/14/2024-0.300
Q3 202311/9/2023-0.350
Q2 20238/2/2023-0.330
Q1 20235/3/2023-0.400
Q4 20222/14/2023-0.280
Q3 202211/3/2022-0.320
Q2 20228/3/2022-0.370
Q1 20225/4/2022-0.440
Q4 20212/15/2022-0.430
Q3 202111/3/2021-0.400
Q2 20218/4/2021-0.350
Q1 20215/5/2021-0.290
Q4 20202/24/2021-0.330
Q3 202011/10/2020-0.270
Q2 20208/10/2020-0.260
Q1 20205/12/2020-0.250
Q4 20192/26/2020-0.170
Q3 201911/12/2019-0.110
Q2 20198/13/2019-1.230
Q3 201611/1/20160.06
Q2 20167/21/20160.48
Q1 20164/20/20160.47
Q4 20152/24/20160.45
Q3 201510/22/20150.31
Q2 20157/23/20150.44
Q1 20154/23/20150.16
Q4 20142/19/20150.09
Q3 201410/29/20140.01
Q2 20147/30/2014-0.22
ADPT Past Revenue
PeriodPast Earnings DateGAAP
Q3 202411/7/20240.05B
Q2 20248/1/20240.04B
Q1 20245/7/20240.04B
Q4 20232/14/20240.05B
Q3 202311/9/20230.04B
Q2 20238/2/20230.05B
Q1 20235/3/20230.04B
Q4 20222/14/20230.06B
Q3 202211/3/20220.05B
Q2 20228/3/20220.04B
Q1 20225/4/20220.04B
Q4 20212/15/20220.04B
Q3 202111/3/20210.04B
Q2 20218/4/20210.04B
Q1 20215/5/20210.04B
Q4 20202/24/20210.03B
Q3 202011/10/20200.03B
Q2 20208/10/20200.02B
Q1 20205/12/20200.02B
Q4 20192/26/20200.02B
Q3 201911/12/20190.03B
Q2 20198/13/20190.02B
Q3 201611/1/201685.37M
Q2 20167/21/2016100.17M
Q1 20164/20/2016112.77M
Q4 20152/24/2016105.43M
Q3 201510/22/201588.21M
Q2 20157/23/201589.59M
Q1 20154/23/201581.45M
Q4 20142/19/201570.08M
Q3 201410/29/201457.60M
Q2 20147/30/201444.24M
Quotes delayed 20 minutes

Email EnvelopeFree ADPT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Adaptive Biotechnologies (ADPT) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ADTX Past Earnings
ADUS Past Earnings
ADVM Past Earnings
ADXS Past Earnings
AEMD Past Earnings
AERI Past Earnings
AFIB Past Earnings
AGEN Past Earnings
AGIO Past Earnings
AGL Past Earnings

ADPT Past Earnings Q&A

What was the best and worst ADPT past earnings results?
For Adaptive Biotechnologies, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest ADPT past earnings result in our data set was 0.48/share posted in Q2 2016, while the lowest was in Q2 2019 when ADPT posted -1.230/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q1 2016 when ADPT reported 112.77M in revenue, while the quarter with the lowest revenue in our data set was Q1 2020 at 0.02B of revenue.

  Suggested answer: There are 32 ADPT past earnings results in our data set.

On this page we presented the ADPT past earnings date information for Adaptive Biotechnologies. Reviewing that ADPT Past Earnings for the company, we see that the highest past earnings result in our data set was in Q2 2016, when ADPT posted gaap of 0.48/share. Meanwhile the lowest ADPT past earnings result was in Q2 2019, when ADPT posted gaap of -1.230/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q1 2016 when ADPT reported 112.77M in revenue, while the smallest revenue quarter was Q1 2020 when ADPT reported 0.02B in revenue.

Any self directed investor doing their due diligence on ADPT or any other given stock can benefit from researching all of the Adaptive Biotechnologies past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Adaptive Biotechnologies past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ADPT. Thanks for visiting, and the next time you need to research ADPT past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: OBK Insider Buying, DAKT Stock Predictions, ZSAN Split History.

 

ADPT Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.